Human T-lymphotropic virus type I excretion and specific antibody response in paired saliva and cervicovaginal secretions

AIDS Research and Human Retroviruses

Volumn 12, Issue 2, 1996, Pages 157-167

  Belec, Laurent ^a   Georges, Alain Jean ^b   Hallouin, Marie Charlotte ^a   Mohamed, Ali Si ^a   Morand Joubert, Laurence ^c   Georges Courbot, Marie Claude ^b  

^a HÔPITAL BROUSSAIS   (France)

^b CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 6; LACTOFERRIN; REX PROTEIN; TAX PROTEIN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; PRIORITY JOURNAL; SALIVA ANALYSIS; SJOEGREN SYNDROME; UTERINE CERVIX; VAGINA SECRETION; VIRUS EXCRETION;

EID: 0030052590     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.157     Document Type: Article

References (46)

1. Höllsberg P and Hafler DA: Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 1993;328:1173-1182.
2. Hino S, Yamaguchi K, Katamine S, Sugiyama H, Amagasaki T, Kinoshita K, Yoshida Y, Doi H, Tsuji Y, and Miyamoto T: Mother-to-child transmission of human T-cell leukemia virus type I. Jpn J Cancer Res 1985;76:474-480.
3. Bartholomew C, Saxinger WC, Clark JW, Gail M, Dudgeon A, Mahabir B, Hull-Drysdale B, Cleghorn F, Gallo RC, and Blattner WA: Transmission of HTLV-I and HIV among homosexual men in Trinidad. JAMA 1987;257:2604-2608.
4. Murphy EL, Figueroa JP, Gibbs WN, Brathwaite A, Holding-Cobham M, Waters D, Crantson B, Hanchard B, and Blattner WA: Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 1989;111:555-560.
5. Archibald D, Essex M, McLane MF, Sauk J, Tachibana N, and Mueller N: Antibodies to HTLV-I in saliva of seropositive individuals from Japan. Viral Immunol 1987/1988;1:241-246.
6. Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H, Yamashita I, Iwata K, Tsuji Y, Nagataki S, and Miyamoto T: Prevalence of serum and salivary antibodies to HTLV-I in Sjögren's syndrome. Lancet 1994;344:116-119.
7. Yamamoto T, Terada K, Nishida N, Moriuchi R, Shirabe S, Nakamura T, Tsuji Y, Miyamoto T, and Katamine S: Inhibitory activity of cell-to-cell transmission of human T-cell lymphotropic virus in vitro: Evaluation of saliva as an alternative source of transmission. J Clin Microbiol 1995;33:1510-1515.
8. Bélec L, Meillet D, Lévy M, Georges AJ, Tévi-Bénissan C, and Pillot J: Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays. Clin Diag Lab Immunol 1995;2:57-61.
9. Lillehoj EP, Alexander SS, Dubrule CJ, Wiktor S, Adams R, Tai C-C, Manns A, and Blattner WA: Development and evaluation of a human T-cell leukemia virus type I serologic confirmatory assay incorporating a recombinant envelope polypeptide. J Clin Microbiol 1990;28:2653-2658.
10. World Health Organization: Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2, and HTLV-I/-II. Wkly Epidemiol Rec 1990;65:281-283.
11. Weiblen BJ, Schumacher RT, and Hoff R: Detection of IgM and IgA antibodies after removal of IgG with recombinant protein G. J Immunol Methods 1990;126:199-204.
12. Hartley TM, Malone GE, Khabbaz RF, Lal RB, and Kaplan JE: Evaluation of a recombinant human T-cell lymphotropic virus type I (HTLV-I) p21e antibody detection enzyme immunoassay as a supplementary test in HTLV-I/II antibody testing algorithms. J Clin Microbiol 1991;29:1125-1127.
13. Bélec L, Tévi-Bénissan C, Lu X-S, Prazuck T, and Pillot J: Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection. AIDS Res Hum Retroviruses 1995;11:719-729.
14. Lu X-S, Delfraissy JF, Grangeot-Keros L, Rannou MT, and Pillot J: Rapid and constant detection of HIV antibody response in saliva of HIV infected patients: Selective distribution of anti-HIV activity in the IgG isotype. Res Virol 1994;145:369-377.
15. Jonard PP, Rambaud JC, Dive C, Vaerman JP, Gallan A, and Delacroix DL: Secretions of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A. J Clin Invest 1984;74:525-535.
16. Pullen GR, Fitzgerald MG, and Hosking CS: Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods 1986;86:83-87.
17. Ferrante P, Colombo E, Magistralli C, Guerini F, Mendozzi E, Cattaneo E, and Achilli G: Utilizzo della PCR e dell'isolamento virale per lo studio delle infezioni da HTLV I e HTLV II. 12th Simposio - Epatite e AIDS, Rimini 1993;222-233.
18. Dekaban GA, King E, Arp J, Palker TJ, and Rice GPA: Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM/TSP patients: An isotype and subclass analysis. Scand J Immunol 1994;40:171-180.
19. Morand-Joubert L, Mariotti M, Reed D, Petit J-C, and Lefrère J-J: Correlation between viral DNA load and serum anti-p19 antibody concentration in symptomless human T-lymphotropic virus type-I (HTLV-I)-infected individuals. Int J Cancer 1995;60:1-4.
20. Parvinen T and Larmas M: Age dependency of stimulated salivary flow rate, pH, and bacillus and yeast concentrations. J Dent Res 1982;61:1052-1055.
21. Wardrop RW, Hailes RJ, Burger H, and Reade PC: Oral discomfort at menopause. Oral Surg Oral Med Oral Pathol 1989; 67:535-540.
22. Waldman RH, Cruz JM, and Rowe DS: Immunoglobulin levels and antibody to Candida albicans in human cervicovaginal secretions. Clin Exp Immunol 1971;10:427-434.
23. Atkinson JC: The role of salivary measurements in the diagnosis of salivary autoimmune diseases. In: Saliva as a Diagnostic Fluid. Malamud D and Tabak L (Eds). The New York Academy of Sciences, New York, 1993, pp. 238-251.
24. Pruitt KM, Rahemtulla F, and Mansson-Rahemtulla B: Innate humoral factors. In: Handbook of Mucosal Immunology. Ogra PL, Strober W, Mestecky J, McGhee JR, Lamm ME, and Bienenstock J (Eds). Academic Press, San Diego, CA, 1994, pp. 53-70.
25. Konttinen YT, Kulomaa M, Malmström M, Kilpi A, and Reitamo S: Lactoferrin in Sjögren's syndrome. Arthritis Rheum 1984;27:462-467.
26. Cox SM, King MR, Casey ML, and MacDonald PC: Interleukin-1 beta, interleukin-1 alpha and interleukin-6 and prostaglandins in vaginal/cervical fluids of pregnant women before and during labor. J Clin Endocrinol Metab 1993;77:805-815.
27. Bélec L, Gherardi R, Payan C, Prazuck T, Malkin J-E, Tévi-Bénissan C, and Pillot J: Proinflammatory cytokine expression in cervicovaginal secretions of normal and HIV-infected women. Cytokine 1995;7:568-574.
28. Brandtzaeg P, Christiansen E, Müller F, and Purvis K: Humoral immune response pattern of human mucosae, including the reproductive tracts. In: Local Immunity in Reproductive Tract Tissues. Griffin PD and Johnson PM (Eds). Oxford University Press, Oxford, 1993, pp. 97-130.
29. Miyoshi I, Sawada T, Iwahara Y, Ishii K, Kubonishi I, and Taguchi H: Excretion of HTLV-I in saliva. JAMA 1992;267:236.
30. Taniguchi S, Maekawa N, Yashiro N, and Hamada T: Detection of human T-cell lymphotropic virus type-1 proviral DNA in the saliva of an adult T-cell leukaemia/lymphoma patients using polymerase chain reaction. Br J Dermatol 1993;129:637-641.
31. Ochert AS, Boulter AW, Birnbaum W, Johnson NW, and Teo CG: Inhibitory effect of salivary fluids on PCR: Potency and removal. PCR Methods Appl 1994;3:365-368.
32. Lane HC, Callihan TR, Jaffe ES, Fauci AS, and Moutsopoulos HM: Presence of intracytoplasmic IgG in the lymphocytic infiltrates of the minor salivary glands of patients with primary Sjögren's syndrome. Clin Exp Rheum 1983;1:237-239.
33. Mariette X, Agbalika F, Daniel M-T, Bisson M, Lagrange P, Brouet J-C, and Morinet F: Detection of human T-lymphotropic virus type I tax gene in salivary gland epithelium from two patients with Sjögren's syndrome. Arthritis Rheum 1993;10:1423-1428.
34. Green JE, Hinrichs SH, Vogel J, and Jay G: Exocrinopathy resembling Sjögren's syndrome in HTLV-I tax transgenic mice. Nature (London) 1989;341:72-74.
35. Bieberich CJ, King CM, Tinkle BT, and Jay G: A transgenic model of transactivation by the tax protein of HTLV-I. Virology 1993;196:309-318.
36. Clapham P, Nagy K, and Weiss R: Pseudotypes of human T-cell leukemia virus type I and II: Neutralization by patients' sera. Proc Natl Acad Sci USA 1984;81:2886-2889.
37. Nagy K, Clapham P, Cheinsong-Popov R, and Weiss R: Human T-cell leukemia virus type I: Induction of syncytia and inhibition by patients' sera. Int J Cancer 1983;32:321-328.
38. Kataoka R, Takehara N, Iwahara Y, Sawada T, Ohtsuki Y, Dawei Y, Hoshino H, and Miyochi I: Transmission of HTLV-I by blood transfusion and its prevention by passive immunization in rabbits sera. Blood 1990;76:1657-1661.
39. Nakamura H, Hayami M, Ohta Y, Ishikawa K, Tsujimoto H, Kiyokawa T, Yoshida M, Sasagawa A, and Honjo S: Protection of cynomolgus monkeys against infection by human T-cell leukemia virus type-I by immunization with viral env gene product produced in Escherichia coli. Int J Cancer 1987;40:403-407.
40. Takehara N, Iwahara Y, Uemura Y, Sawada T, Ohtsuki Y, Iwai H, Hoshino H, and Miyoshi I: Effect of immunization on HTLV-I infection in rabbits. Int J Cancer 1989;44:332-336.
41. Tanaka Y, Zeng L, Shiraki H, Shida H, and Tozawa H: Identification of a neutralizing epitope on the envelope gp46 antigen of human T cell leukemia virus type 1 and induction of neutralizing antibody by peptide immunization. J Immunol 1991; 147:354-360.
42. Baba E, Nakamura M, Tanaka Y, Kuroki M, Itoyama Y, Nakano S, and Niho Y: Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine. J Immunol 1993;151:1013-1024.
43. Desgranges C, Souche S, Vernant J-C, Smadja D, Vahlne A, and Horal P: Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera. AIDS Res Hum Retro-viruses 1994;10:163-173.
44. Tanaka Y, Tanaka R, Terada E, Koyanagi Y, Miyano-Kurosaki N, Yamamoto N, Baba E, Nakamura M, and Shida H: Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization. J Virol 1994;68:6323-6331.
45. Kajiyama W, Kashiwagi S, Ikematsu H, Hayashi J, Nomura H, and Okochi K: Intrafamilial transmission of adult T-cell leukemia virus. J Infect Dis 1986;154:851-857.
46. Riedel DA, Evans AS, Saxinger C, and Blattner WA: A historical study of human T-lymphotropic virus type I transmission in Barbados. J Infect Dis 1989;159:603-609.